Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/03/2005 | US20050048649 Generating and identifying shuffled plasmid variants comprising linearizing circular plasmid, introduce plasmid into host cell, cultivating cell, screening for recombined gene sequences and polypeptides |
03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
03/03/2005 | US20050048633 Novel carbonyl reductase, gene encoding the same, and process for producing optically active alcohols using the same |
03/03/2005 | US20050048631 Which have enhanced activity of enzymes involved in conversion of 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole (AICAR) to inosine-5'-monophosphate (IMP), such as AICAR-transformylase-IMP cyclohydrolase |
03/03/2005 | US20050048630 Nucleic acids encoding beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni |
03/03/2005 | US20050048613 Expression vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of lung and or colon tumors; antitumor agents |
03/03/2005 | US20050048604 Site directed mutatgenesis; deletions; transferases; hybridization probes |
03/03/2005 | US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy |
03/03/2005 | US20050048586 Using taste transduction G-protein coupled receptor polypeptides as diagnostic tools which identify modulators which enhance flavors and taste |
03/03/2005 | US20050048570 Solid support comprising microstructures containing biofunctionalized nanoparticles for use in detecting infection; disease diagnosis; bioinformatics |
03/03/2005 | US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides |
03/03/2005 | US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay |
03/03/2005 | US20050048523 Nucleic acid molecules encoding multiple start codons and histidine tags |
03/03/2005 | US20050048522 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
03/03/2005 | US20050048520 Nogo receptor homologs |
03/03/2005 | US20050048510 Aquifex aeolicus delta prime polymerase subunit and use thereof |
03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
03/03/2005 | US20050048484 Cytochrome p450 monooxygenases consisting of thermophilic bacteria |
03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
03/03/2005 | US20050048471 Albumin derivatives with therapeutic functions |
03/03/2005 | US20050048076 Mutant endotoxin for use in prevention of bacterial infections; bactericides; microbiocides |
03/03/2005 | US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
03/03/2005 | US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
03/03/2005 | DE10335796A1 Verschliessen von Bakterienghosts durch bioaffine Wechselwirkungen Closing of bacterial ghosts by bioaffinity interactions |
03/03/2005 | CA2536495A1 Promoter of synoviolin gene |
03/03/2005 | CA2536363A1 Abiogenic transition unit |
03/03/2005 | CA2535951A1 Bacterial strains, compositions including same and probiotic use thereof |
03/03/2005 | CA2535745A1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
03/03/2005 | CA2535362A1 Lactic acid bacteria capable of stimulating mucosal immunity |
03/03/2005 | CA2535353A1 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
03/03/2005 | CA2531400A1 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
03/03/2005 | CA2531146A1 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
03/02/2005 | EP1510585A1 A method for regulating plant growth |
03/02/2005 | EP1510583A1 Process for producing mevalonic acid |
03/02/2005 | EP1510582A1 Method for producing L-amino acid using bacterium of Enterobacteriaceae family, having nir operon inactivated |
03/02/2005 | EP1510581A1 Nobel glyphosate-tolerant 5-enolpyruvylshikimate-3-phospha synthase and gene encoding it |
03/02/2005 | EP1510573A1 Method for detoxification of mycotoxins |
03/02/2005 | EP1510570A2 Method for producing L-histidine using bacteria of enterobacteriaceae family |
03/02/2005 | EP1509615A1 Screening method for regulatory enzymes employing tribrid (tri-hybrid) system |
03/02/2005 | EP1509608A1 Methods of purification of cytochrome p450 proteins and of their crystallizing |
03/02/2005 | EP1509607A1 Immunogenic sequences |
03/02/2005 | EP1509606A1 Allergen from mugwort pollen |
03/02/2005 | EP1509603A1 Methods, compositions and kits for cell separation |
03/02/2005 | EP1509596A1 Translocation dependent complementation for drug screening |
03/02/2005 | EP1509541A2 Novel recombinant anticoagulant proteins |
03/02/2005 | EP1509539A2 Novel compositions and methods for cancer |
03/02/2005 | EP1421115B1 Soluble t cell receptor |
03/02/2005 | EP1341922B1 Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination |
03/02/2005 | EP1214421B1 Stachybotrys phenol oxidizing enzyme |
03/02/2005 | EP1198475B1 Highly purified cytokine activating factor and methods of use |
03/02/2005 | EP1141294B1 Method of enhancing the biological activity of ligands |
03/02/2005 | EP0907731B1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses |
03/02/2005 | EP0905232B1 Beta 1-4 N-ACETYLGLUCOSAMINYLTRANSFERASE AND GENE ENCODING THE SAME |
03/02/2005 | EP0851027B1 Method for controlling culture of lactic bacteria |
03/02/2005 | EP0850299B1 Combined ligand and receptor display |
03/02/2005 | EP0799311B1 Human chemokine beta-9 |
03/02/2005 | EP0783582B1 PROCESS OF PRODUCING $g(b)-LACTAM ANTIBIOTICS APPLYING MICROORGANISMS WITH INCREASED LIGASE ACTIVITY |
03/02/2005 | EP0690916B1 Pesticidal proteins and strains |
03/02/2005 | EP0659215B1 Production of phytate degrading enzymes in trichoderma |
03/02/2005 | CN1589327A Plant enzymes for bioconversion |
03/02/2005 | CN1589324A Genes coding for phosphoenopyruvate-sugar-phosphotransferase proteins |
03/02/2005 | CN1589323A Bacillus D747 strain, plant disease controlling agents or insect pest controlling agents using the same and control method using the agents |
03/02/2005 | CN1589239A Organic waste treatment |
03/02/2005 | CN1587399A Producing new fibrinolysin from rhizopchin |
03/02/2005 | CN1587388A Recombined enteroaerogen and its use |
03/02/2005 | CN1587387A Method for producing hyaluronic acid and its special strain |
03/02/2005 | CN1587386A Method for producing hyaluronic acid and its special strain |
03/02/2005 | CN1587385A High efficiency experssino human glicentin-1 gene engineering bacteria and its construction method and use |
03/02/2005 | CN1587384A Antibiotic peptide gene converted viscons bacillus engineering bacterium and its preparing method and use |
03/02/2005 | CN1587383A New method for modifying clavulanic acid producing bacteria and high yield clavulanic acid producing bacteria |
03/02/2005 | CN1587382A Method for promoting methane oxidizing bacteria growth |
03/02/2005 | CN1587381A Sea micromonoad antibiotic active substance fermentation promoter |
03/02/2005 | CN1587380A Method for producing pyruvic acid by smooth Torulopsis strain and fermentation |
03/02/2005 | CN1587379A Bacteria growing inhibiting culture medium of white rot fungus degrading active dye in non-sterilized environment |
03/02/2005 | CN1587378A Separating and screening method for arachindonic acid high yield strain |
03/02/2005 | CN1587377A Lecanium verticillin and cultivatnig method and use |
03/02/2005 | CN1587376A Lecanium verticillin and cultivating method and use |
03/02/2005 | CN1587375A Cultivating method for scarab green muscardine fungus solid state fermentation |
03/02/2005 | CN1587374A Northen Chinese caterpillar fungus culture medium |
03/02/2005 | CN1587373A Use of L-arginine, L-ornithine or L-citrulline as spirulina princeps growing regulator |
03/02/2005 | CN1587372A Farm composite bacteria prepn and preparing method |
03/02/2005 | CN1587215A Organic fertilizer and its preparing method |
03/02/2005 | CN1587042A Process for preparing water glass from acid separation filtrate |
03/02/2005 | CN1586296A Functional food capable of removing hydroxy free radical in body and its preparing method |
03/02/2005 | CN1191369C Process for producing adenosylmethionine by metabolic engineering bacteria |
03/02/2005 | CN1191362C Streptococcus antigens |
03/02/2005 | CN1191361C Carrot anti-freeze polypeptides |
03/02/2005 | CN1191357C Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
03/02/2005 | CN1191353C Thuringiensis bacillus strain for killing noctridae pests and its preparing process |
03/02/2005 | CN1191347C Cleaning compositions contg. multiply-substd-protease variants |
03/02/2005 | CN1191271C Thymic peptide fusion protein as one new interferon and its prepn. |
03/02/2005 | CN1191270C Cellulose binding domain |
03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
03/01/2005 | US6861513 Everninomicin biosynthetic genes |
03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
03/01/2005 | US6861258 Deactivating and deleting a characteristic gene defining a detectable host characteristic and inserting a DNA fragment of interest into the modified host together with intact characteristic gene enabling confirmation of integration |
03/01/2005 | US6861245 Production of heterologous polypeptides from freshwater caulobacter |
03/01/2005 | US6861242 Reacting glucosidase and phosphotransferase |